Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment
Authors
Keywords
Alirocumab, LDL-C, Monoclonal antibody, Open-label, PCSK9
Journal
INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume 228, Issue -, Pages 754-760
Publisher
Elsevier BV
Online
2016-11-09
DOI
10.1016/j.ijcard.2016.11.046

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.